Amanote Research
Register
Sign In
Synthesis of SMO Inhibitor PF-04449913
Synfacts
doi 10.1055/s-0033-1341076
Full Text
Open PDF
Abstract
Available in
full text
Date
April 17, 2014
Authors
Unknown
Publisher
Georg Thieme Verlag KG
Related search
Genetic Mutations Predict SMO Inhibitor Response in SHH Medulloblastoma
Cancer Discovery
Oncology
Evaluation of the Effects of Formulation, Food, or a Proton-Pump Inhibitor on the Pharmacokinetics of Glasdegib (PF-04449913) in Healthy Volunteers: A Randomized Phase I Study
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Synthesis and Biological Evaluation of BODIPY-PF-543
Molecules
Organic Chemistry
Molecular Medicine
Analytical Chemistry
Theoretical Chemistry
Pharmaceutical Science
Medicine
Drug Discovery
Chemistry
Physical
Small-Molecule P21-Activated Kinase Inhibitor PF-3758309 Is a Potent Inhibitor of Oncogenic Signaling and Tumor Growth
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Met Tyrosine Kinase Inhibitor, PF-2341066, Suppresses Growth and Invasion of Nasopharyngeal Carcinoma
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Biomarker and Pharmacologic Evaluation of the -Secretase Inhibitor PF-03084014 in Breast Cancer Models
Clinical Cancer Research
Cancer Research
Oncology
Kje Smo Izgubili »zakaje«?
Metodički obzori/Methodological Horizons
Synthesis of a PCSK9 Inhibitor
Synfacts
Smoothened (SMO); Suppressor of Fused Homolog (SUFU)
Science-Business eXchange
